Basic Information
Basic information for LINC02223-219-25aa
Peptide Name LINC02223-219-25aa
Genome Position chr5:17930096-17930170[+]
Species Human
Peptide Sequence MLRSRYCLLGEVSTVREKLEVWCHL
Peptide Length 25
Unique No (LINC02223-205-25aa-1,LINC02223-206-25aa,LINC02223-207-25aa,LINC02223-208-25aa,LINC02223-212-25aa,LINC02223-213-25aa,LINC02223-214-25aa,LINC02223-215-25aa,LINC02223-216-25aa)
Grand Average of Hydropathicity 0.1
Relative Molecular Mass 3453.99
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000249937;LINC02223
Transcript ID/Name ENST00000670782;LINC02223-219
Transcript Length 1596
Coding Ability 0.4392
DNA Sequence Corresponding to Peptide ATGTTAAGAAGTAGATACTGTTTGTTAGGAGAAGTGTCCACAGTTAGGGAGAAGTTAGAGGTCTGGTGTCATCTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :